The priority review user fee required by this subsection shall be
due upon the submission of a human drug application under section 505 (b)(1) or section 351 (a) of the Public Health Service Act for which the priority review voucher is used.
See also the emphasis on «equal and
due treatment» in the Canadian Supreme Court's recent discussion of placing «
due weight on Aboriginal perspectives» and ensuring its supporting evidence an «equal footing» in Mitchell v Minister of Natural Revenue [2001] 1 SCR 911, relied
upon the State of Victoria in the present appeal as correctly setting out the applicable approach: Written
Submissions of the First Respondent (State of Victoria), at 16.